388 related articles for article (PubMed ID: 31491724)
1. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
2. Achaete-scute complex homologue 2 accelerates the development of Sjögren's syndrome-like disease in the NOD/ShiLtJ mouse.
Kim SM; Kwon JE; Park JS; Seo HB; Jung KA; Moon YM; Lee J; Kwok SK; Cho ML; Park SH
Immunol Lett; 2017 Oct; 190():26-33. PubMed ID: 28728856
[TBL] [Abstract][Full Text] [Related]
3. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB
Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230
[TBL] [Abstract][Full Text] [Related]
4. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
5. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
[TBL] [Abstract][Full Text] [Related]
7. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
8. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
9. IL-27 Regulated CD4
Qi J; Zhang Z; Tang X; Li W; Chen W; Yao G
Front Immunol; 2020; 11():1699. PubMed ID: 32849596
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
11. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
12. Local suppression of IL-21 in submandibular glands retards the development of Sjögren's syndrome in non-obese diabetic mice.
Liu H; Liu G; Gong L; Zhang Y; Jiang G
J Oral Pathol Med; 2012 Nov; 41(10):728-35. PubMed ID: 22643047
[TBL] [Abstract][Full Text] [Related]
13. Metabolic abnormalities exacerbate Sjögren's syndrome by and is associated with increased the population of interleukin-17-producing cells in NOD/ShiLtJ mice.
Hwang SH; Park JS; Yang S; Jung KA; Choi J; Kwok SK; Park SH; Cho ML
J Transl Med; 2020 May; 18(1):186. PubMed ID: 32370746
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
15. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?
Sellam J; Miceli-Richard C; Gottenberg JE; Proust A; Ittah M; Lavie F; Loiseau P; Mariette X
Rheumatology (Oxford); 2008 Apr; 47(4):437-41. PubMed ID: 18296721
[TBL] [Abstract][Full Text] [Related]
16. Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjögren's syndrome.
Chen W; Yang F; Xu G; Ma J; Lin J
J Leukoc Biol; 2021 Feb; 109(2):437-447. PubMed ID: 33325085
[TBL] [Abstract][Full Text] [Related]
17. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
[TBL] [Abstract][Full Text] [Related]
18. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.
Hayakawa I; Tedder TF; Zhuang Y
Immunology; 2007 Sep; 122(1):73-9. PubMed ID: 17472721
[TBL] [Abstract][Full Text] [Related]
19. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma.
Pontarini E; Murray-Brown WJ; Croia C; Lucchesi D; Conway J; Rivellese F; Fossati-Jimack L; Astorri E; Prediletto E; Corsiero E; Romana Delvecchio F; Coleby R; Gelbhardt E; Bono A; Baldini C; Puxeddu I; Ruscitti P; Giacomelli R; Barone F; Fisher B; Bowman SJ; Colafrancesco S; Priori R; Sutcliffe N; Challacombe S; Carlesso G; Tappuni A; Pitzalis C; Bombardieri M
Ann Rheum Dis; 2020 Dec; 79(12):1588-1599. PubMed ID: 32963045
[TBL] [Abstract][Full Text] [Related]
20. IL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22.
Wu C; Wang Z; Zourelias L; Thakker H; Passineau MJ
Arthritis Res Ther; 2015 Aug; 17(1):198. PubMed ID: 26245278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
